According to a new report from Intel Market Research, the global Digital Product Engineering Service market was valued at USD 2,239 million in 2024 and is projected to reach USD 3,122 million by 2032, growing at a CAGR of 5.5% during the forecast period (2025–2032). This growth is propelled by accelerating digital transformation initiatives across industries, rising adoption of cloud-native architectures, and increasing demand for AI-powered product development solutions.
Read MoreAccording to a new report from Intel Market Research, the global Regenerated Lyocell Fiber market was valued at USD 965 million in 2024 and is projected to reach USD 1.96 billion by 2031, growing at a robust CAGR of 11.7% during the forecast period (2025–2031). This growth is driven by increasing consumer demand for sustainable textiles, stringent environmental regulations favoring green alternatives, and the textile industry's fundamental shift toward embracing circular economy principles.
Read MoreAccording to a new report from Intel Market Research, the global Visual Novel market was valued at US$ 263.73 million in 2023 and is projected to reach US$ 620.24 million by 2030, growing at a robust CAGR of 10.51% during the forecast period (2024–2030). This expansion is fueled by increasing consumer demand for interactive narrative experiences, the democratization of game development tools, and strategic expansions into previously untapped regional markets.
Read MoreAccording to a new report from Intel Market Research, the global fiberglass needle felt market was valued at USD 71.5 million in 2024 and is projected to reach USD 91.6 million by 2031, growing at a steady CAGR of 3.7% during the forecast period (2025–2031). This growth is driven by increasing industrialization, stringent environmental regulations, and expanding applications across construction and filtration sectors.
Read MoreAccording to a new report from Intel Market Research, the global Metoprolol Succinate API market was valued at USD 1.07 billion in 2024 and is projected to reach USD 1.43 billion by 2031, growing at a CAGR of 4.2% during the forecast period. This growth is primarily driven by increasing cardiovascular disease prevalence, expansion of generic drug markets, and advancements in extended-release formulation technologies.
Read More